Valion Bio Inc (VBIO) Financials

$2.51

$-0.29 (-10.36%)

As on 01-Oct-2026 16:20EDT

Market cap

$3 Mln

Revenue (TTM)

$2 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19
Operating Revenue	1.87	0.38	--	1.18	1.84	1.26
Cost of Revenue	0.65	0.35	0.35	0.89	1.54	1.30
Gross Profit	-0.81	0.03	-0.35	0.29	0.30	-0.05
Operating Expenses	15.71	7.90	4.06	8.53	10.40	5.59
Operating Profit (EBIT)	-16.52	-7.90	-4.42	-8.25	-10.10	-5.63
Other Income	--	--	--	--	--	--
Profit before Tax	-17.84	-7.99	-4.47	-8.24	-10.10	-8.49
Provision for Tax	--	--	--	--	--	--
Profit after Tax (Net Income)	-18.75	-8.88	-5.66	-8.24	-10.10	-8.49
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	--

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19
Shareholder's Funds	11.89	16.80	2.54	3.58	3.63	13.27
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	17.54	14.16	--	0.18	0.37	0.54
Current Liabilities	3.05	0.65	0.27	1.40	1.88	1.22
Total Liabilities	35.52	31.61	2.81	5.16	5.88	15.04

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19
Non-Current Assets	29.09	18.60	0.17	0.51	0.57	0.75
Current Assets	3.38	13.01	2.64	4.65	5.31	14.29
Total Assets	35.52	31.61	2.81	5.16	5.88	15.04
Total Debt*	17.41	6.45	--	0.37	0.53	0.71
Net Current Assets	0.34	12.36	2.37	3.25	3.43	--

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19
Cash From Operating Activities	--	-7.00	-5.73	-8.51	-8.92	-5.61
Cash Flow from Investing Activities	--	-0.71	--	-0.12	-0.01	--
Cash from Financing Activities	--	18.35	4.33	8.51	-0.53	17.54
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19
Adjusted EPS ($)	-69.47	-39.95	-10.15	-95.64	-1,771.23	-1,490.18
Cash EPS ($)	--	-39.93	-9.52	-93.53	-1,740.70	-1,490.18
Adjusted Book Value ($)	--	75.59	4.55	41.53	636.84	2,328.42
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-31.50	-10.28	-98.74	-1,564.74	-984.56
Free Cash Flow per Share ($)	--	-31.67	-10.28	-100.10	-1,566.67	-984.56

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19
ROCE (%)	--	-68.86	-174.43	-203.33	-111.31	-114.45
ROE (%)	-130.74	-91.85	-184.96	-228.68	-119.47	-120.18
ROA (%)	-91.80	-51.60	-142.01	-149.46	-96.56	-106.62
EBIT Margin (%)	-745.03	-2,054.19	--	-701.11	-548.80	-448.13
Net Margin (%)	-1,003.19	-2,324.08	--	-701.02	-548.70	-675.74
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19
Revenue Growth (%)	376.80	--	-1.00	-0.36	0.46	0.46
EBIT Growth (%)	-121.70	-77.69	46.44	18.35	-79.27	-69.62
Net Profit Growth (%)	-195.69	-56.99	31.40	18.34	-18.86	-133.42
EPS Growth (%)	6.93	-2.94	0.89	0.95	-0.19	-1.25
Book Value Growth (%)	2,001.23	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19
Price / Earnings	--	-0.04	-0.58	-0.32	-0.61	-4.43
Price / Book Value	0.52	0.02	1.29	0.74	1.71	2.83
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	--	0.75	-0.31	0.05	-0.32	-4.52
Close Price ($)	13.00	36.25	147.05	765.00	27,200.00	164,900.00
High Price ($)	140.00	391.00	952.00	36,125.00	172,975.00	276,250.00
Low Price ($)	11.51	35.00	85.43	488.75	21,675.00	140,675.00
Market Cap ($ Cr)	2.69	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19
Debt to Equity	0.62	0.38	--	0.10	0.15	0.05
Short term debt to equity ratio	0.04	0.03	--	0.05	0.04	0.01
Current Ratio	1.11	20.13	9.70	3.32	2.83	11.72
Quick Ratio	0.86	--	8.53	2.78	2.37	11.37
Interest Coverage	-11.95	-53.75	--	--	--	-3.09

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Mar-21	Dec-20	Mar-20	Dec-19	Mar-19
Debtors to sales (%)	76.95	0.26	--	14.80	5.82	7.32
Asset Turnover	0.09	0.02	--	0.21	0.18	0.16
Receivable days	--	33.47	--	43.64	19.75	26.73
Inventory Days	--	332.90	557.73	332.59	153.12	120.25
Payable days	--	202.97	434.77	418.25	250.29	115.27
Cash Conversion Cycle	--	163.39	--	-42.03	-77.43	31.72

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.